{"a":[{"_":"Scholar Rock scores long-awaited FDA approval, the first for muscle loss in SMA","$":{"href":"/ai-and-machine-learning/scholar-rockscores-long-awaited-fda-approval-first-muscle-loss-sma","hreflang":"en"}}]}
RegulatoryapprovedPositive
AI Analysis
Summary
Scholar Rock has received FDA approval for an injectable monoclonal antibody, marking the first treatment approved to address muscle atrophy in patients with spinal muscular atrophy (SMA).
Outcome Details
FDA approval for injectable monoclonal antibody to treat muscle atrophy in patients with SMA
Importance:9/10
Sentiment:
0.90
FDA approvalmonoclonal antibodySMAmuscle atrophyfirst-in-class
Related Companies
Read the original article
Published by FiercePharma on September 14, 2026 10:40 AM
